Amina Zoubeidi

2775 Laurel Street
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Editorial Expression of Concern: GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.

Editorial Expression of Concern: GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.

Journal: Oncogene

Published: March 30, 2026

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Journal: Molecular cancer research : MCR

Published: November 28, 2025

Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target.

Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 13, 2025

Correction: Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.

Correction: Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.

Journal: Journal of biomedical science

Published: November 09, 2025

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity.

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity.

Journal: The Journal of clinical investigation

Published: September 15, 2025

Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers.

Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers.

Journal: iScience

Published: September 04, 2025

Retraction Notice to: ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.

Retraction Notice to: ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.

Journal: Cell reports

Published: August 10, 2025

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

Journal: JCI insight

Published: August 08, 2025

New frontiers in prostate cancer treatment from systemic therapy to targeted therapy.

New frontiers in prostate cancer treatment from systemic therapy to targeted therapy.

Journal: EMBO molecular medicine

Published: May 07, 2025

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

Journal: Cell reports

Published: April 05, 2025

Correction to: Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch.

Correction to: Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch.

Journal: Cell death and differentiation

Published: March 18, 2025

LKB1 inactivation unleashes prostate cancer lineage plasticity.

LKB1 inactivation unleashes prostate cancer lineage plasticity.

Journal: Cell research

Published: January 01, 2025

Showing 1-12 of 140

Last Updated: 09/26/2026